ciprofloxacin + doxycycline

**Ciprofloxacin + doxycycline** is a combination of two antibiotics, **ciprofloxacin** (a fluoroquinolone) and **doxycycline** (a tetracycline), used together as a prophylactic or therapeutic regimen for bacterial infections, including infection prevention in neutropenic patients post-autologous stem cell transplant for multiple myeloma, and has been studied for potential use in other serious or resistant bacterial infections. - **Ciprofloxacin** acts by inhibiting bacterial DNA gyrase and topoisomerase IV, effectively preventing DNA replication and transcription. - **Doxycycline** inhibits the 30S ribosomal subunit, thereby blocking protein synthesis in bacteria. This combination has shown to be effective in reducing infection rates when compared to ciprofloxacin alone in specific high-risk patient populations[1]. The synergistic or suppressive interplay between their mechanisms may also affect bacterial resistance patterns[4]. No well-established brand name exists for this exact fixed combination, and the regimen typically involves co-administration of the individual drugs.